Ikarian Capital, LLC

Position in PRQR — ProQR Therapeutics N.V.

CIK 1778253 DALLAS, TX

Position in PRQR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,417,410

-$596,892 QoQ

Shares Held

1,492,229

0.0% QoQ

Ownership

1.06%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $659,799,686 across 106 Biotechnology names. PRQR ranks #59 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	1,456,378	$76,780,248
2	KOD	Kodiak Sciences Inc.	1,265,795	$48,252,105
3	ALMS	Alumis Inc.	1,213,548	$26,734,462
4	PCVX	Vaxcyte, Inc.	428,682	$24,910,711
5	PRAX	Praxis Precision Medicines, Inc.	71,581	$23,062,682
6	RLMD	Relmada Therapeutics, Inc.	2,688,359	$18,710,978
7	CYTK	Cytokinetics Inc	283,572	$18,690,230
8	TENX	Tenax Therapeutics, Inc.	1,017,600	$16,271,424

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,417,410	1,492,229	0.0%	Shares	Sole	2026-05-15
2025-12-31	$3,014,302	1,492,229	+67.2%	Shares	Sole	2026-02-18
2025-09-30	$1,900,447	892,229	+2.8%	Shares	Sole	2025-11-14
2025-06-30	$1,770,860	868,069	+79.5%	Shares	Sole	2025-08-14
2024-09-30	$880,121	483,583	0.0%	Shares	Sole	2024-11-14
2024-06-30	$802,747	483,583	0.0%	Shares	Sole	2024-08-14
2024-03-31	$1,107,405	483,583	+2.3%	Shares	Sole	2024-05-17
2023-12-31	$935,797	472,625	0.0%	Shares	Sole	2024-02-14
2023-09-30	$614,412	472,625	0.0%	Shares	Sole	2023-11-14
2023-06-30	$765,652	472,625	0.0%	Shares	Sole	2023-08-14
2023-03-31	$1,006,691	472,625	+11.8%	Shares	Sole	2023-05-15
2022-12-31	$1,563,712	422,625	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.